SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 151 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,213,000 | +85.8% | 197,565 | +82.3% | 0.00% | +100.0% |
| Q2 2017 | $1,191,000 | +74.6% | 108,349 | +55.6% | 0.00% | 0.0% |
| Q1 2017 | $682,000 | -45.1% | 69,622 | -39.5% | 0.00% | 0.0% |
| Q4 2016 | $1,242,000 | +145.5% | 115,077 | +133.1% | 0.00% | – |
| Q3 2016 | $506,000 | +39.4% | 49,376 | +77.4% | 0.00% | – |
| Q2 2016 | $363,000 | -34.4% | 27,827 | -44.7% | 0.00% | -100.0% |
| Q1 2016 | $553,000 | +123.9% | 50,291 | +87.5% | 0.00% | – |
| Q4 2015 | $247,000 | +648.5% | 26,816 | +465.0% | 0.00% | – |
| Q3 2015 | $33,000 | -78.3% | 4,746 | -69.4% | 0.00% | – |
| Q2 2015 | $152,000 | +52.0% | 15,490 | +37.1% | 0.00% | – |
| Q1 2015 | $100,000 | -47.6% | 11,301 | -48.4% | 0.00% | – |
| Q4 2014 | $191,000 | +558.6% | 21,892 | +418.6% | 0.00% | – |
| Q3 2014 | $29,000 | +26.1% | 4,221 | -4.3% | 0.00% | – |
| Q2 2014 | $23,000 | -69.3% | 4,410 | -73.1% | 0.00% | – |
| Q1 2014 | $75,000 | -36.4% | 16,420 | -29.5% | 0.00% | – |
| Q4 2013 | $118,000 | +61.6% | 23,295 | +59.8% | 0.00% | – |
| Q3 2013 | $73,000 | -28.4% | 14,579 | -29.5% | 0.00% | – |
| Q2 2013 | $102,000 | – | 20,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|